Angiotensin inhibitors mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin Inhibitors Mechanism of Action: Key Pathways
Inhibition of Angiotensin II Formation and Vasoconstriction
Angiotensin-converting enzyme inhibitors (ACE inhibitors) work mainly by blocking the conversion of angiotensin I to angiotensin II, a powerful vasoconstrictor. By reducing angiotensin II levels, these drugs lower blood pressure, decrease vasoconstriction, and reduce sodium and water retention, which helps improve heart function and relieve symptoms in conditions like heart failure and hypertension De Lacerda2024Behnia2003Petrillo1982+2 MORE.
Enhancement of Bradykinin and Vasodilation
ACE inhibitors also prevent the breakdown of bradykinin, a molecule that promotes blood vessel relaxation (vasodilation). This dual action—reducing angiotensin II and increasing bradykinin—leads to improved blood flow and further blood pressure reduction De Lacerda2024Regulski2015Henriksen2003. The increased bradykinin can also stimulate nitric oxide (NO) production, which helps relax blood vessels and may enhance glucose uptake in muscle tissue, especially in insulin-resistant states .
Antifibrotic and Anti-Inflammatory Effects
Beyond blood pressure control, ACE inhibitors have been shown to reduce tissue fibrosis (scarring) and inflammation in the heart. They do this by blocking the breakdown of N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), a natural antifibrotic peptide. This leads to less collagen buildup, reduced cell proliferation, and lower levels of inflammatory markers in the heart, which is particularly beneficial in conditions like heart failure and hypertension Peng2005Fish1994.
Direct Activation of Bradykinin B1 Receptors
Some ACE inhibitors can directly activate bradykinin B1 receptors, even in the absence of their usual ligands. This activation increases calcium levels in cells and triggers the release of nitric oxide, which may contribute to the drugs’ therapeutic effects and some side effects .
Inhibition of Cardiac and Vascular Growth
Angiotensin II is not only a vasoconstrictor but also acts as a growth factor for heart and vascular smooth muscle cells. By blocking angiotensin II formation, ACE inhibitors can prevent or reverse abnormal growth and remodeling of the heart and blood vessels, offering additional protection in cardiovascular diseases .
Additional Mechanisms: Prostaglandins and Antioxidant Effects
Some ACE inhibitors, especially those containing sulfhydryl groups, may also act as antioxidants or stimulate the production of protective prostaglandins. These actions can help improve heart muscle function after injury and may differ depending on the specific chemical structure of the ACE inhibitor used .
Conclusion
Angiotensin inhibitors, particularly ACE inhibitors, lower blood pressure and protect the heart and kidneys through several mechanisms: blocking angiotensin II formation, enhancing bradykinin and nitric oxide, reducing tissue fibrosis and inflammation, inhibiting abnormal tissue growth, and in some cases, providing antioxidant and prostaglandin-mediated benefits. These combined actions explain their wide use and effectiveness in treating cardiovascular and renal diseases Ignjatovic2002Peng2005De Lacerda2024+7 MORE.
Sources and full results
Most relevant research papers on this topic